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Abstract
Aim There is a recognized need to include the views of
patients and the public in prioritizing health research.
This study aimed: (i) to explore patients’ views on col-
orectal research; and (ii) to prioritize research topics
with patients and the public.
Method In phase 1, 12 charitable organizations and
patient groups with an interest in bowel disease were
invited to attend a consultation exercise. Participants
were briefed on 25 colorectal research topics prioritized
by members of the Association of Coloproctology of
Great Britain and Ireland. Focus groups were con-
ducted and discussions were recorded with field notes.
Analysis was conducted using principles of thematic
analysis. In phase 2, a free public consultation was
undertaken. Participants were recruited from newspaper
advertisements, were briefed on the same research topics
and were asked to rate the importance of each on a
five-point Likert scale. Descriptive statistics were used
to rank the topics. Univariable linear regression com-
pared recorded demographic details with mean topic
scores.
Results Focus groups were attended by 12 patients
who highlighted the importance of patient-centred
information for trial recruitment and when selecting
outcome measures. Some 360 people attended the
public consultation, of whom 277 (77%) were
recruited. Participants rated ‘What is the best way to
treat early cancer in the back passage?’ highest, with
227 (85%) scoring it 4 or 5. There was no correla-
tion between participant demographics and mean
topic scores.
Conclusion The present study prioritized a colorectal
research agenda with the input of patients and the pub-
lic. Further research is required to translate this agenda
into real improvements in patient care.
Keywords Patient and public involvement, research
methodology, research priorities, bowel disease, out-
come selection, priority setting partnership
What does this paper add to the literature?
Patient and public involvement in research is critical to
ensure appropriate resource allocation, but there are no
evidence-based guidelines for research in colorectal sur-
gery. The study explored patients’ views on key colorec-
tal research topics and prioritized their importance. It is
recommended that this agenda is used to plan future
patient-centred research.
Introduction
Surgical research is burdened by specific difficulties that
have led to a paucity of high-quality studies and trials
[1–3]. Traditionally, academics have defined research
topics and designed studies without the involvement of
those who have direct experience of disease and its
treatment. Recent publications have called for the
involvement of patients and their representatives in
research at a much earlier stage, ideally helping to
define research topics that they perceive to be of value
[4–6]. This has been helped by funding bodies, patient
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groups, editors and health policy makers who place an
emphasis on patient and public consultation when
designing clinical research [2–4,7–9].
Since 2004, the James Lind Alliance (JLA) has devel-
oped a Priority Setting Partnership (PSP) to enable
patients, carers and clinicians to work together to iden-
tify and prioritize uncertainties about treatment. Their
recent round table report, a collaboration between the
National Institute for Clinical Excellence (NICE), the
JLA, Association of Medical Research Charities
(AMRC) and member charities, highlighted ‘a need to
increase the perceived power of patient views’ and
demonstrated strong support for programmes including
research questions based on prioritized patient, carer
and clinician input [10].
There is a demonstrable mismatch between the views
of clinicians and patients in identifying topics for
research [7]. This is particularly relevant in colorectal
surgery, in which the potential benefits are balanced
against the potential of the long-term deleterious
impact on quality of life. The balance between the ben-
efits and risks of colorectal surgery is perhaps best illus-
trated in perianal Crohn’s disease [11] but is also well-
recognized in cancer treatment [12,13]. Appropriately,
therefore, much research has been carried out to
explore patients’ treatment preferences in colorectal sur-
gery [14]. There is, however, little evidence demon-
strating which colorectal surgical topic should be the
focus of research.
The Association of Coloproctology of Great Britain
and Ireland (ACPGBI) has recently conducted a modi-
fied Delphi exercise to define research priorities in
bowel disease, with the financial and administrative sup-
port of its research charity, the Bowel Disease Research
Foundation (BDRF) [15]. Delphi methodology is an
established technique for reaching a consensus opinion
among a group of experts and is used commonly in the
health and social sciences [16–19]. The entire ACPGBI
membership of practising colorectal surgeons was sur-
veyed and this generated over 500 potential research
questions. Through a series of iterative voting rounds, a
list of 25 prioritized research questions was identified:
15 relating to colorectal cancer and 10 relating to
diverse topics, including benign disease, surgical tech-
nique and clinical governance.
In the current study the questions were posed to
patients to gather a collective patient and public per-
spective on the prioritized areas of research, to focus on
patient-centred outcomes, views and values. The views
were obtained before developing research strategies
based on the questions, and, most importantly, to allow
patients to define their own order of priority. The over-
all aims were: (i) to explore patients’ views on the
research topics; and (ii) to prioritize research topics with
the input of patients and the public. It is anticipated
that this novel approach will enable genuine and inte-
grated patient collaboration in defining and developing
future research for questions relating to bowel disease.
Method
The scope of this consultation exercise included
patients, carers, family and members of the public with
an interest in bowel disease, including cancer, inflamma-
tory bowel disease or other benign conditions. Paedi-
atric colorectal disease was excluded. The study is
presented in two phases as follows: (i) exploration of
patients’ views on the research topics; and (ii) prioritiza-
tion of the research topics.
Phase 1: Exploration of patients’ views on the
research topic
Charitable organizations and patient groups with an
interest in bowel disease were invited to attend a 1-day
consultation exercise in March 2015, hosted by the
Royal College of Surgeons of England in London, UK.
The organizations present included the BDRF, the
ACPGBI, the Colostomy Association, the British Soci-
ety of Gastroenterology, IA, the Ileostomy and Internal
Pouch Support Group, Crohn’s and Colitis United
Kingdom (CCUK), the Kingston Trust, Beating Bowel
Cancer, Bowel Cancer United Kingdom, the Core
Charity, the National Institute for Health Research
Consumer Liaison Group and the Royal College of Sur-
geons of England Patient Liaison Group. Consultant
surgeons and surgical trainees with an interest in
research prioritization were invited to participate
through personal correspondence. The chairwoman
(AV) was a patient and Trustee of the BDRF and
CCUK and is experienced in patient consultation
exercises.
Personal introductions were made by all participants
at the outset of the meeting to gain an understanding
of their background and role in the exercise. The 25
research questions identified from the ACPGBI profes-
sional Delphi exercise research agenda were then sum-
marized in lay language. Participants were divided into
focus groups consisting of patients, surgical trainees and
practising consultant surgeons to explore patients’ views
on each research topic. Focus groups varied in size from
six to 10 participants, and each session, discussing an
individual topic, lasted for approximately 30 min. All
groups were supported by consultant surgeons with an
in-depth understanding of colorectal disease. Discus-
sions were centred on the one open-ended question of
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‘What do you feel is important about [the topic] from a
patient’s perspective?’. Patients were free to discuss any
views they considered relevant. Clinicians explained
medical terminology or research methodology, and pro-
vided a clinical perspective when this was sought by
patients. Following each session, participants fed back
their views on each topic to the wider group. Disparate
opinions were actively sought and discussed.
Data collection and analysis
Data were collected in the form of anonymized field
notes created by eight participating observers in the
focus groups. These included consultant or trainee sur-
geons with an in-depth understanding of colorectal dis-
ease. Researchers were the participating observers and
recorded patients’ views on the research topics and their
rationale on notepads. Direct quotations were recorded
to illustrate patients’ views where appropriate. The par-
ticipating observers were provided with guidance by the
senior study team but received no formal training. Anal-
ysis was conducted using the principles of qualitative
thematic analysis [20]. Field notes were read and re-
read through a process of data familiarization. Sections
of text were coded independently by two researchers
(NF and AM) and a preliminary set of themes was
developed. A process of constant comparison between
field notes was used to refine the themes and deviant
cases were sought to challenge emerging theories. The
themes were discussed with the wider research team and
further refined. Data are presented as three main
themes, with quotation of the source documents pro-
vided as illustration.
Phase 2: Patient and public prioritization
Patient prioritization was conducted during the consul-
tation exercise (described above). Blinding to clinician
prioritization was ensured by random allocation of
questions to letters of the Greek alphabet. Public priori-
tization was conducted at a free event at the Digestive
Disorders Federation conference held in June 2015,
London, UK. Participants were recruited through
advertising in the London Evening Standard newspaper
and through marketing material created by the BDRF
and the Core Charity. Included were any individuals
who wanted to prioritize bowel disease research (such
as patients, carers, family members and healthy individu-
als) and there were no exclusions.
Patients and the public participants were presented
with a summary of each research question in lay lan-
guage, and were then asked to rate its importance on a
five-point Likert scale with scores ranging from 1
(lowest priority) to 5 (highest priority). One question
was added to the voting at the request of the funder
(CORE): ‘How can diet, probiotics and medicines help
in irritable bowel syndrome?’. Clinical and sociodemo-
graphic details were recorded in the public consultation
and included sex, age, country of residence, self-
reported healthcare problems, past surgical history and
presence of stoma. Self-reported healthcare problems
were defined as ‘cancer’, ‘inflammatory bowel disease’,
‘other bowel disease’, ‘other nonbowel disease’ or
‘none’. Past surgical history was defined as ‘bowel
surgery’, ‘bottom surgery’, ‘other surgery’ or ‘none’.
Analysis
Research topics were categorized as ‘high priority’ if
they were rated as 4 or 5 on the Likert scale and as
‘low priority’ if they were rated as 1 or 2. Descriptive
statistics were used to rank the importance of the
research topics. Public consultation data are presented
overall, and with subgroup analysis of those participants
who identified themselves as patients. Univariable linear
regression was used to explore the association between
mean question scores and clinical and sociodemographic
variables in the public consultation. There were no a
priori assumptions that were planned to be analysed in
a multivariable model.
Results
Phase 1: Exploration of patients’ views on the
research topic
There were 25 participants in the initial patient consul-
tation exercise: 11 patients, each with personal experi-
ence of bowel disease; one administrator from the host
charity; nine colorectal consultants; and four general
surgical trainees. Geographical representation included
England, Wales and Scotland. The major themes identi-
fied through discussion of the 25 questions were: (i)
that patients were supportive of research questions; (ii)
the importance of good communication; and (iii) the
importance of selecting patient-centred outcomes in
research. These themes are discussed in more detail
below.
Patients were supportive of the research questions
Patients expressed support for all the research questions,
a view that was explained by an altruistic attitude
towards future sufferers of bowel disease. Of paramount
importance was patient-centred research, in which dis-
ease sufferers are involved in the design of research
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questions, including consideration of the intervention
involved in the trial and identification of the outcome
measures.
Patients’ support was extended to the inclusion of
anonymized patient information on national databases.
There was unanimous recognition of the essential role
that such databases play in designing research studies
but also in potentially highlighting dangerous or inef-
fective treatments. High-quality large-scale information
with appropriate, but not inhibitory, data protection
and sharing was felt to be in the common interest for
patients and researchers alike. National tissue banks and
extra biopsy samples were considered acceptable to aid
scientific progression if they could provide more accu-
rate ways of treating cancer and allow tailor-made per-
sonalized treatments.
Concern about some of the research questions was
raised, however. Avoiding delays in treatment after
initial diagnosis was a high priority for patients as
‘once I knew I had cancer, I wanted to start treat-
ment tomorrow’ (discussion of question Alpha). The
need for prompt treatment was highlighted in the
context of tumour progression ‘it might sound weird,
but I had an idea that if I sat in a quiet room,
I could hear the tumour growing’ (discussion of
question Eta). Acceptance of delay to allow enrolment
in trials would need to be clearly explained with good
communication about research studies, re-affirming
that delay would not have a negative impact on suc-
cessful outcome but may actually carry potential bene-
fit, especially if neoadjuvant intervention is the
proposed research intervention.
The importance of good communication
Patients’ desire for high-quality information during
study recruitment was reflected in discussions about
every research question. Patients were of the opinion
that ‘it’s the information you are given’ (discussion of
question Delta) and ‘the way you, the clinician, put the
questions across’ that best informs the decision to take
part in research. ‘Communication is key’ (discussion of
question Phi) when presenting different treatment
options in the recruitment phase, taking time to discuss
complications and manage patient expectations.
Most patients felt overwhelmed by the amount of
information given when told of the diagnosis, for exam-
ple, ‘the first day I found out about cancer was not the
right day to talk about my treatment options’ (discus-
sion of question Iota). Giving information for recruit-
ment into research requires careful explanation and
allowing patients ‘time to digest information’.
Trust in the clinician was felt to be a major
influence for recruitment to trials. One patient said,
‘Do not underestimate the trust and respect a patient
has in their clinician, you are in the hands of the
professionals’ (discussion of question Delta). Although
‘people trust their doctors to give them good advice’
patients would like their views to be taken into
account.
Particular emphasis was placed on the communica-
tion of information about stomas. This was not in
response to any specific research question, but was
highlighted across the focus groups. Patients were crit-
ical of a stoma being presented as a treatment failure:
‘A stoma is not a negative thing. Patients don’t want a
small stoma – they want one that works, not an attrac-
tive one. If a surgeon feels for even one moment that
a stoma is a bad thing, then that is what stays in your
head’ (Discussion of question Xi). Patients felt that it
is unacceptable for the medical profession to present a
stoma as a last resort, and that there must be a more
positive message, ‘I’ll give you a stoma, and your qual-
ity of life will be much improved’. Patients felt that it
was more important to communicate that ‘having a
stoma does not stop you from having a full and active
life’ (discussion of question Xi), and importantly that
it may be the best available therapeutic option to
regain health. Likewise, implication that a stoma was
temporary, when it was likely to be permanent, was
felt to be negative as patients tended to put life on
hold, pending a reversal that would probably never
happen for good medical reasons. Patients also
expressed the need for better information about how
to avoid stoma complications, particularly parastomal
hernia, and to be given sufficient advice and support
on discharge.
The importance of patient-centred outcome selection
The selection of patient-centred end-points was con-
sidered important by the focus groups. For example,
concern was raised about evaluating fistulating perianal
Crohn’s disease by measuring rates of healing or
recurrence. Participants instead described the need to
evaluate the impact of treatment on quality of life
such as ‘a measure of lost nights of sleep’ (discussion
of question Eta). In other benign conditions, it was
noted that ‘Improved function is more important
than recurrence as it improves quality of life’ (discus-
sion of question Upsilon). Where there was a lack of
patient-centred outcomes available, participants voiced
the need for their involvement in developing them in
the future.
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In cancer-related questions, patients considered
long-term survival to be critical, with views such as
‘Only do a smaller surgery if you are able to remove
the cancer properly’ (discussion of question Eta).
Surgeons should ‘be specific in how damage is mea-
sured’ (discussion of question Eta) because anxiety
generated from fear of recurrence and spread can be
a strong motivator for overtreatment. Patients
reported anxiety about the effects of surgery and
radiotherapy on bladder, bowel and sexual function,
and of the toxicity of chemotherapy and radiotherapy,
but wanted specific information on how this would
affect them as an individual rather than that given in
overall statistics. Survival was not the only important
Table 1 Prioritization of cancer questions in patient consultation: proportion of participants rating each question as ‘low’ (1 or 2
on the Likert scale) or ‘high’ (4 or 5 on the Likert scale) in importance (n = 12).
Question Category
Low
importance
High
importance
n % n %
What is the impact of treatment for bowel and anal cancers
on quality of life?
Cancer 0 12 100
How do we improve screening for bowel cancer? Cancer 0 12 100
How do we personalize treatment for cancer of the back
passage using genetics?
Cancer 0 11 92
Why do some patients develop spread from bowel cancer? Cancer 0 10 83
Which polyps predict risk of developing bowel cancer? Cancer 1 9 9 75
What is the best way to check that cancers of the back
passage do not come back?
Cancer 1 10 8 67
What is the best way to look after patients with Crohn’s
disease with fistulas around their bottoms?
Noncancer 0 8 67
What are the best ways to prevent and fix hernias beside
stomas?
Noncancer 2 18 8 67
Does reporting surgeon outcomes improve care? Noncancer 2 18 8 67
How can we improve care for patients with severe infection
related to their bowels?
Noncancer 0 8 67
What is the best way to treat early cancers in the back passage? Cancer 0 6 50
When should a join in the bowel have a temporary stoma
made above the join?
Noncancer 2 18 6 50
How do we best treat polyp cancers removed at colonoscopy? Cancer 1 9 6 50
When should we operate to remove bowel cancer that has
spread to the liver or lungs?
Cancer 1 9 6 50
Is chemotherapy better before or after surgery for more
advanced bowel cancers?
Cancer 3 27 5 42
When is it best to use surgery to remove Crohn’s disease
affecting the bowel?
Noncancer 0 5 42
Is there benefit from preoperative radiotherapy in back
passage cancers which could be removed with surgery?
Cancer 1 9 5 42
What is the best way to close the ‘hole’ when the anus is
removed?
Noncancer 1 9 5 42
What is the best way to look after patients with infection from
diverticulitis?
Noncancer 2 18 5 42
How can we reduce the chances of leakage from a join in the
bowel?
Noncancer 3 27 4 36
Can problems with defaecation be improved by surgery? Noncancer 2 18 4 36
Is a more radical approach to surgery for advanced cancers in
the back passage beneficial?
Cancer 2 18 3 27
How do we stop the bowel going on ‘strike’ after surgery? Noncancer 2 18 3 27
How should we treat patients with cancer in the back passage
if they have a really good response to chemoradiotherapy?
Cancer 4 36 2 18
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outcome to patients and researchers were urged to
‘also look at functional outcomes, not just survival
and recurrence’.
Phase 2: Patient and public prioritization
Patient prioritization
The results of the patient prioritization exercise are pre-
sented in Table 1. Overall, the cancer questions
received the highest priority, with questions about qual-
ity of life after bowel cancer treatment and screening
receiving maximum scores. Other key cancer priorities
were perceived as personalization of treatment through
knowledge of genetic prediction and prevention of
metastatic disease. This order of priority contrasted
markedly with the prioritization favoured by the sur-
geon by whom questions about organ preservation in
rectal cancer treatment were ranked highest.
Although noncancer questions did not achieve scores
at the same level as cancer questions, there was a signifi-
cant cluster of high-scoring questions related to the
outcome after anastomotic leakage, intra-abdominal
sepsis and fistulating perianal Crohn’s disease. There
was a wide spread of scoring of the questions in this
exercise, which may be a reflection of the preceding in-
depth consultations held.
Public consultation
The public consultation exercise was attended by 360
patients, carers and lay representatives, of whom 277
(77%) completed demographic registration forms and
were included in the final analysis. Participant demo-
graphics are reported in Table 2. A minority (n = 77;
25%) identified themselves as patients; half (n = 146;
49%) were women and most (n = 212; 71%) were
between 40 and 80 years of age. Univariable linear
regression did not identify any correlation between
demographic variables and mean question rating scores,
and a multivariable model was therefore not constructed
(Table 3).
Results of the public prioritization exercise are pre-
sented in Table 4. There were some missing responses.
Most complete was the question ‘How can we improve
care for patients with severe infection related to their
bowels?’ (271/277; 98%) and least complete was ‘How
can diet, probiotics and medicine help in irritable bowel
syndrome?’ (257/277; 93%). Ratings of cancer and non-
cancer questions were much more heterogeneous in this
exercise, but were still rated highly. The highest rated
question was ‘What is the best way to treat early cancers
in the back passage?’ [227 (85% of respondents) gave a
rating of high importance and five (2%) gave a rating of
low importance] followed by ‘How can we reduce the
chances of leakage from a join in the bowel?’ [222 (83%
of respondents) gave a rating of high importance and 13
(5%) gave a rating of low importance]. The lowest rated
question was ‘Does reporting surgeon outcomes improve
Table 2 Demographics of participants in public and lay
consultations.
Variable All participants Patients
Total 277 80
Sex
Female 146 (53) 41 (51)
Male 99 (36) 31 (39)
Not declared 32 (11) 8 (10)
Age (years)
< 40 51 (18) 8 (10)
41–60 105 (38) 36 (45)
61–80 107 (39) 30 (38)
> 80 5 (2) 3 (4)
Not declared 9 (3) 3 (4)
Location
England 262 (95) 79 (99)
Wales 2 (1) 1 (1)
Outside UK 2 (1) 0
Not declared 11 (4) 0
Surgery
Yes 48 (17) 27 (34)
No 209 (75) 48 (60)
Not declared 20 (8) 5 (6)
Stoma
Yes 2 (1) 1 (1)
No 256 (92) 74 (93)
Not declared 19 (7) 5 (6)
Values are given as n (%).
Table 3 Univariable linear regression of total mean score
according to participant characteristics.
Characteristic n
Difference in
mean score 95% CI P
Participant
Nonpatient* 176 0
Patient 77 0.1 0.1 to 0.3 0.25
Sex
Female* 145 0
Male 98 0.1 0.2 to 0.1 0.24
Age (years)
21–40* 51 0
41–60 105 0.2 0.0 to 0.4
61–80 107 0.3 0.1 to 0.5
< 80 5 0.2 0.4 to 0.7 0.06
Surgery
No* 27 0
Yes 48 0.1 0.4 to 0.2 0.43
*Baseline category for comparison.
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Table 4 Prioritization of cancer questions by all participants attending the public consultation: proportion of participants rating
each question as ‘low’ (1 or 2 on the Likert scale) or ‘high’ (4 or 5 on the Likert scale) in importance.
Question Category
Total no. of
participants
Low
importance
High
importance
n % n %
What is the best way to treat early cancers
in the back passage?
Cancer 268 5 2 227 85
How can we reduce the chances of leakage
from a join in the bowel?
Noncancer 268 13 5 222 83
Which polyps predict risk of developing
bowel cancer?
Cancer 269 15 6 220 82
How can diet, probiotics and medicines help
in irritable bowel syndrome?
Noncancer 257 15 6 210 82
How can we improve care for patients with
severe infection related to their bowels?
Noncancer 271 18 7 214 79
What is the best way to check that cancers
of the back passage do not come back?
Cancer 266 17 6 206 77
What is the best way to look after patients
with Crohn’s disease with fistulas around
their bottoms?
Noncancer 266 15 6 205 77
How do we personalize treatment for cancer
of the back passage using genetics?
Cancer 264 22 8 201 76
How do we improve screening for bowel
cancer?
Cancer 269 31 12 204 76
Why do some patients develop spread from
bowel cancer?
Cancer 265 21 8 196 74
What is the best way to close the ‘hole’ when
the anus is removed?
Noncancer 267 27 10 187 70
How do we best treat polyp cancers removed
at colonoscopy?
Cancer 270 18 7 187 69
What is the impact of treatment for bowel
and anal cancers on quality of life?
Cancer 267 22 8 184 69
What is the best way to look after patients
with infection from diverticulitis?
Noncancer 270 28 10 177 66
Is chemotherapy better before or after surgery
for more advanced bowel cancers?
Cancer 266 40 15 160 60
How should we treat patients with cancer in the
back passage if they have a really good response
to chemoradiotherapy?
Cancer 264 44 17 156 59
Is a more radical approach to surgery for
advanced cancers in the back passage beneficial?
Cancer 267 40 15 151 57
If bowel cancer has spread but responds to
chemotherapy, is it worth operating on the
primary bowel tumour?
Cancer 261 32 12 145 56
When should we operate to remove bowel cancer
that has spread to the liver or lungs?
Cancer 264 48 18 148 56
When is it best to use surgery to remove
Crohn’s disease affecting the bowel?
Noncancer 263 43 16 148 56
When should a join in the bowel have a
temporary stoma made above the join?
Noncancer 263 38 14 145 55
What are the best ways to prevent and fix hernias
beside stomas?
Noncancer 266 53 20 139 52
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care?’ [131 (49%) gave a rating of high importance and
60 (23%) gave a rating of low importance]. Subgroup
analysis on those who identified themselves as patients is
presented in Table 5. The highest rated question was
‘How can diet, probiotics and medicines help in irritable
bowel syndrome?’ [60 (89% of respondents) gave a rating
of high importance and two (3%) gave a rating of low
importance]. The lowest rated question for the patient
subgroup was the same as the whole group, namely
‘Does reporting surgeon outcomes improve care?’ [30
(44%) gave a rating of high importance and 16 (23%)
gave a rating of low importance].
Discussion
This patient and public consultation exercise explored
patients’ views on colorectal research topics and priori-
tized questions for further research. In the patient con-
sultation exercise, participants were found to be
supportive of the research questions and highlighted
the importance of patient-centred information for
recruitment to trials and when selecting outcome mea-
sures. Participants, in general, prioritized cancer-related
research questions above others, with the top six ques-
tions relating to the early diagnosis, treatment and fol-
low up of colorectal cancer. The public consultation
exercise was more heterogeneous in prioritizing cancer
and noncancer topics. Of note is the high rating of
‘How can diet, probiotics and medicines help in irrita-
ble bowel syndrome?’, which was fourth highest in the
public consultation exercise. Professionals did not iden-
tify this issue to be an important research topic [15],
and it was added to this study at the request of the fun-
der. This finding may represent a potential mismatch
between the importance placed on irritable bowel syn-
drome research by professionals and the public. Further
research is needed to explore this issue further and
explain the implications for colorectal research.
No other patient or public consultation exercises
were identified in the field of colorectal diseases, but
comparisons can be made with professionals’ prioritiza-
tion of research topics. Over 918 members of the
ACPGBI were surveyed on this issue and the response
rate was low, at 239 (26%) [15]. The highest rated can-
cer question related to the treatment of early rectal can-
cer and the highest rated noncancer question was on
the detection of anastomotic leakage, although effect
sizes were not reported. A survey of members of the
American Society of Colon and Rectal Surgeons simi-
larly found research on the treatment of rectal cancer to
be the most important research question [18]. Some-
what surprisingly, given the evidence that the research
community and patients often disagree [21], these
topics are exactly those identified as the most important
in this public prioritization exercise and offers good tri-
angulation of the present study.
The study is the largest patient and public consulta-
tion exercise in colorectal disease undertaken to date,
but there are some limitations. The findings from the
qualitative study (phase 1) in particular should be inter-
preted with caution. Data were collected from focus
groups by way of field notes that were taken by several
different researchers without transcribed audio record-
ings. This significantly weakens the scientific rigour in a
number of ways. It has not been possible to provide a
reflective account of all researchers to outline how per-
sonal experiences may have resulted in methodological
bias. Similarly, note taking was completed in an incon-
sistent manner, which makes transparent interpretation
of the findings difficult. Rich and thick verbatim
descriptions [22], commonly used in qualitative
research to support findings in sufficient detail to allow
extrapolation to other circumstances, were often lack-
ing, which limits the ability of the study to demonstrate
clear thought processes during data analysis. The quali-
tative results of this study have nonetheless been
Table 4 (Continued).
Question Category
Total no. of
participants
Low
importance
High
importance
n % n %
Can problems with defaecation be improved by
surgery?
Noncancer 264 64 24 134 51
Is there benefit from preoperative radiotherapy in
back passage cancers which could be removed
with surgery?
Cancer 264 43 16 130 49
How do we stop the bowel going on ‘strike’
after surgery?
Noncancer 264 59 22 130 49
Does reporting surgeon outcomes improve care? Noncancer 265 60 23 131 49
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Table 5 Prioritization of cancer questions by those reporting themselves to be ‘patients’ in the public consultation: proportion of
participants rating each question as ‘low’ (1 or 2 on the Likert scale) or ‘high’ (4 or 5 on the Likert scale) in importance.
Question Category
Total no.
of patients
Low
importance
High
importance
n % n %
How can diet, probiotics and medicines help in
irritable bowel syndrome?
Noncancer 73 2 3 60 89
What is the best way to treat early cancers in the
back passage?
Cancer 73 2 3 59 81
How do we improve screening for bowel cancer? Noncancer 71 4 5 58 81
How can we improve care for patients with
severe infection related to their bowels?
Noncancer 71 5 7 59 81
What is the best way to look after patients with
Crohn’s disease with fistulas around their bottoms?
Noncancer 77 3 4 58 80
How do we personalize treatment for cancer of
the back passage using genetics?
Cancer 73 5 7 54 78
What is the best way to check that cancers of the
back passage do not come back?
Cancer 71 4 5 55 77
What is the best way to look after patients with
infection from diverticulitis?
Noncancer 69 7 9 56 77
How can we reduce the chances of leakage from
a join in the bowel?
Noncancer 73 3 4 55 76
Which polyps predict risk of developing bowel
cancer?
Cancer 67 6 8 56 75
What is the best way to close the ‘hole’ when the
anus is removed?
Noncancer 69 5 7 53 72
How do we best treat polyp cancers removed at
colonoscopy?
Cancer 73 6 8 52 71
Why do some patients develop spread from bowel
cancer?
Cancer 73 4 5 55 71
What is the impact of treatment for bowel and
anal cancers on quality of life?
Cancer 73 5 7 53 71
How should we treat patients with cancer in the
back passage if they have a really good response
to chemoradiotherapy?
Cancer 75 10 13 47 64
When should we operate to remove bowel cancer
that has spread to the liver or lungs?
Cancer 75 11 15 44 62
If bowel cancer has spread but responds to
chemotherapy, is it worth operating on the
primary bowel tumour?
Cancer 73 6 8 43 61
Is chemotherapy better before or after surgery for
more advanced bowel cancers?
Cancer 71 12 16 44 60
What are the best ways to prevent and fix hernias
beside stomas?
Noncancer 71 8 11 42 57
How do we stop the bowel going on ‘strike’ after
surgery?
Noncancer 71 16 23 39 56
When is it best to use surgery to remove Crohn’s
disease affecting the bowel?
Noncancer 73 9 12 38 54
Is a more radical approach to surgery for advanced
cancers in the back passage beneficial?
Cancer 69 10 14 38 54
When should a join in the bowel have a temporary
stoma made above the join?
Noncancer 69 9 14 37 53
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included because it was felt that they were useful sup-
porting data despite these limitations. The findings
could be explored more rigorously in future research.
The principal weakness of the public consultation exer-
cise is potential selection bias. Participants were
recruited from public advertisements and there were no
exclusion criteria. It is likely that attendees share certain
characteristics that could affect their responses in a way
not representative of the UK population as a whole.
This may, for example, include the patient’s clinical
condition, education, level of deprivation or ethnicity.
Furthermore, it should be noted that another speaker
was discussing treatment options for irritable bowel syn-
drome at the same public event – it may be the reason
why this question scored highly. The public consulta-
tion meeting involved the prioritization of many topics
in a short period of time. It is therefore important to
consider the potential that participants were over-
whelmed by information. For example, participants may
become fatigued and stop providing scores for ques-
tions; however, this did not seem to be the case as the
numbers of participants providing scores were stable
(257–271; Table 4). Likewise, if participants were over-
loaded and unable to differentiate between different
questions, then the responses may be homogeneous.
These data, however, showed a good spread of
responses.
The aim of this study was to define a patient-centred
research agenda. Now, efforts need to be focussed on
designing and conducting high-quality research in these
areas. The ACPGBI has begun this process by holding a
series of ‘Delphi Games’, in which multidisciplinary
groups of individuals meet to discuss each question and
begin to form a research programme. As a direct result,
several major studies have been funded in the areas of
parastomal hernia (CIPHER) [23], perianal Crohn’s
disease (ENiGMA) and organ-preserving surgery for
rectal cancer (STAR-TREC). In accordance with the
findings of this study, patients have been included in all
these working groups to help define the subject of
research and the design of the study. Engagement also
needs to come from funding bodies. The BDRF has
committed research funding to these research questions
for a period of 18 months, and other organizations are
called upon to recognize the importance of these issues
to the colorectal patient community. Further research is
also needed to identify further patient-centred areas of
research that were not included in this study.
In conclusion, the present study has prioritized a col-
orectal research agenda in collaboration with patients
and the public, and has demonstrated patients’ ongoing
support for this programme. Further research is
required to translate this agenda into real improvement
in patient care. ‘The great thing about the Delphi
ORACLE is that it appeases some of the antagonism
between patients and doctors, bringing together the
knowledge from objective experts, the clinicians, with
the knowledge of the subjective experts, the patients’.
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